Table 2.
The cycle characteristics and outcomes of the couples with infected HPV (Group I) and non-infected male partners (Group II)
| Variable | Group I (n=9) | Group II (n=108) | p |
|---|---|---|---|
| Cycle duration (days) | 10 (9–15) | 11 (8–18) | >0.05 |
| Estradiol levels* (pg/mL) | 1667 (355–2264) | 2218 (732–6897) | >0.05 |
| Endometrial thickness (mm) | 12 (8–14) | 11 (7–15) | >0.05 |
| No. of retrieved oocytes | 7 (1–11) | 8 (1–26) | >0.05 |
| No. of MII oocytes | 6 (1–10) | 7 (1–20) | >0.05 |
| Fertilization rate (%) | 82.5 (25–100) | 76.5 (33–100) | >0.05 |
| No. of Grade I embryos | 1 (0–2) | 2 (0–9) | <0.003a |
| Implantation rate (%) | 29 | 33 | >0.05 |
| Positive HCG, n (%) | 4 (44) | 44 (40) | >0.05 |
| Clinical pregnancy rate, n (%) | 1 (11) | 31 (28) | >0.05 |
| Pregnancy loss, n (%) | 3 (33) | 11 (10) | >0.05 |
Values are presented as median (minimum–maximum). NS: statistically not significant (p>0.05). astatistically significant